ES8306323A1 - Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa. - Google Patents

Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.

Info

Publication number
ES8306323A1
ES8306323A1 ES506320A ES506320A ES8306323A1 ES 8306323 A1 ES8306323 A1 ES 8306323A1 ES 506320 A ES506320 A ES 506320A ES 506320 A ES506320 A ES 506320A ES 8306323 A1 ES8306323 A1 ES 8306323A1
Authority
ES
Spain
Prior art keywords
oral administration
coagulation factor
pharmaceutical composition
factor viii
administration containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506320A
Other languages
English (en)
Spanish (es)
Other versions
ES506320A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of ES506320A0 publication Critical patent/ES506320A0/es
Publication of ES8306323A1 publication Critical patent/ES8306323A1/es
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES506320A 1980-10-17 1981-10-16 Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa. Expired ES8306323A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55144508A JPS5770814A (en) 1980-10-17 1980-10-17 Oral preparation of blood clotting eighth factor

Publications (2)

Publication Number Publication Date
ES506320A0 ES506320A0 (es) 1983-05-16
ES8306323A1 true ES8306323A1 (es) 1983-05-16

Family

ID=15363986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506320A Expired ES8306323A1 (es) 1980-10-17 1981-10-16 Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.

Country Status (5)

Country Link
JP (1) JPS5770814A (enrdf_load_stackoverflow)
DE (1) DE3141223A1 (enrdf_load_stackoverflow)
ES (1) ES8306323A1 (enrdf_load_stackoverflow)
FR (1) FR2492260A1 (enrdf_load_stackoverflow)
GB (1) GB2085729B (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536392A (en) * 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
IT1164363B (it) * 1983-08-03 1987-04-08 Foscama Biomed Chim Farma Procedimento terapeutico facente uso di liposomi imcorporati fruttosio 1,6 difosfato e procedimento per la preparazione degli stessi
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
FR2581543B1 (fr) * 1985-05-09 1989-07-07 Tressens Dominique Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4115453A1 (de) * 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
FR2706302B1 (fr) * 1993-06-18 1995-08-18 Franche Comte Universite Produit alcalinisant sous forme gastro-résistante.
DE4416180C2 (de) * 1994-05-06 1997-08-14 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats
US6017891A (en) * 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
CH689139A5 (de) * 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
CA2303200A1 (en) * 1997-09-04 1999-03-11 Brian C. Keller Oral liposomal delivery system
DE60035260T2 (de) 1999-02-22 2007-10-18 The University Of Connecticut, Farmington Neue albuminfreie faktor viii formulierungen
AU2009313325B2 (en) 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
DE102009001334B4 (de) 2009-03-04 2017-02-23 Stefan Brosig Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen
CN109316599A (zh) * 2018-08-24 2019-02-12 上海交通大学医学院附属瑞金医院 一种抑肽酶或其突变体、衍生物、类似物或其组成片段的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
NL7900459A (nl) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D Farmaceutisch preparaat en werkwijze ter bereiding daarvan.

Also Published As

Publication number Publication date
JPH03366B2 (enrdf_load_stackoverflow) 1991-01-07
GB2085729B (en) 1984-04-18
ES506320A0 (es) 1983-05-16
JPS5770814A (en) 1982-05-01
GB2085729A (en) 1982-05-06
FR2492260A1 (fr) 1982-04-23
DE3141223A1 (de) 1982-06-24
FR2492260B1 (enrdf_load_stackoverflow) 1984-07-27

Similar Documents

Publication Publication Date Title
ES8306323A1 (es) Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.
GB2117777B (en) Carboxyalkyl dipeptides processes for their production and pharmaceutical compositions containing them
NO892293D0 (no) Fremgangsmaate for fremstilling av et terapeutisk produkt.
IL89900A0 (en) Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
PT77503A (en) Process for preparing pharmaceutical compositions for oral and/or enteral administration
ZA83362B (en) Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
EP0494972A4 (en) Effervescent dosage form and method of administering same
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
GB9009390D0 (en) Pharmaceutical compositions
EP0352903A3 (en) Bovine factor xa inhibiting factor and pharmaceutical compositions containing the same
GB8829556D0 (en) New cyclosporin crystal form processes for its production pharmaceutical compositions containing it and its use
GB2259647B (en) Medicaments for treating gastrointestinal disorders
JPS5234935A (en) Medicinal composition
DK486189A (da) Psyllium-froeskaller og midler omfattende samme
DE69804865D1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
HU9400447D0 (en) Purified streptogramins process for producing them and pharmaceutical compositions containing them
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
ZA889540B (en) New cyclosporin crystal form,processes for its production,pharmaceutical compositions containing it and its use
JPS57145859A (en) 1-carboxyalkanoylindoline-2-carboxylic acids, manufacture thereof, phamaceutical medicine containing them and treatment thereby
ZA917700B (en) Peptide and pseudopeptide compounds that are therapeutically active in the blood coagulation cascade,process for the preparation thereof,and pharmaceutical compositions containing them
IL81477A0 (en) Bradykinin type peptides and pharmaceutical compositions containing the same
JO1821B1 (en) New pharmaceutical product
HUT47286A (en) Process for producing benzylaminoaryl-dihydropyridine-lactones and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980203